This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.

Sponsored by Washington University School of Medicine

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.

Target enrollment

U.S. states

Aug 2025

Start date

Dec 2029

Expected completion

Interventions / Treatments

[18F] FZTA

Multiple Sclerosis

Missouri1 site

St Louis

Compare treatment centers near a trial site by center type, providers and trials.

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.